
52.60 Delayed Data As of Jan 30 | ![]() Today’s Change | 40.69 Today|||52-Week Range 115.34 | +16.86% Year-to-Date |
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates Jan 24 / Zacks.com - Paid Partner Content |
Previous close | 52.58 |
Today’s open | 52.73 |
Day’s range | 52.59 - 54.36 |
Volume | 2,865,116 |
Average volume (3 months) | 2,849,422 |
Market cap | $9.7B |
Earnings growth (last year) | -9.24% |
Earnings growth (this year) | -15.94% |
Earnings growth (next 5 years) | +4.95% |
Revenue growth (last year) | +20.76% |
P/E ratio | 22.4 |
Price/Sales | 3.96 |
Price/Book | 2.01 |
Today’s change | Today’s % change | |
---|---|---|
JAZZJazz Pharmaceuticals... | -1.76 | -1.13% |
RGENRepligen Corp | -14.88 | -7.63% |
RDYDr Reddy's Laborator... | +0.18 | +0.34% |
SRPTSarepta Therapeutics... | -2.04 | -1.66% |
Next reporting date | February 7, 2023 |
EPS forecast (this quarter) | $0.69 |
Annual revenue (last year) | $4.8B |
Annual profit (last year) | $503.0M |
Net profit margin | 10.42% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Somerset, New Jersey |